In ₹ Crore except Per Share 12 Months Ending | FY19 31/03/2019 | FY20 31/03/2020 | FY21 31/03/2021 | Last 12M 30/09/2021 | |
|---|---|---|---|---|---|
| Revenue from Operations | — | 0.4 | 0.2 | 0.3 | |
| Other Income | — | 0.9 | 0.7 | 1.8 | |
| Total Income | — | 1.3 | 0.9 | 2.1 | |
| Expenses | |||||
| + Cost of Materials Consumed | — | 0.3 | 0.2 | 0.3 | |
| + Changes in Inventories | — | 0.0 | 0.0 | 0.0 | |
| + Employee Benefit Expense | — | 0.2 | 0.3 | 0.3 | |
| + Finance Costs | — | 0.0 | 0.7 | 1.0 | |
| + Depreciation & Amortisation | — | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | — | 0.2 | 0.1 | 0.7 | |
| Total Expenses | — | 0.8 | 1.3 | 2.3 | |
| EBITDA | — | -0.4 | -0.4 | -0.9 | |
| EBIT | — | -0.5 | -0.4 | -1.0 | |
| Profit | |||||
| PBT before Exceptional Items | — | 0.5 | -0.4 | -0.1 | |
| + Exceptional Items | — | -0.8 | -2.6 | -2.0 | |
| Pretax Income | — | -0.3 | -3.0 | -2.2 | |
| + Current Tax | — | 0.0 | 0.0 | 0.0 | |
| Tax Expense | — | 0.0 | 0.0 | 0.0 | |
| + Share of Associates & JVs | — | 0.0 | 0.0 | -0.5 | |
| Net Income | — | -0.3 | -3.0 | -2.7 | |
| + Net Income — Continuing Ops | — | -0.3 | -3.0 | -2.2 | |
| + Other Comprehensive Income | — | -0.0 | 0.0 | 0.0 | |
| Total Comprehensive Income | — | -0.3 | -3.0 | -2.7 | |
| Per Share | |||||
| Basic EPS | — | -2.44 | -5.01 | -6.46 | |
| Diluted EPS | — | -2.44 | -5.01 | -6.46 | |
| Per Share — as-filed variants | |||||
| Basic EPS — Continuing Operations | — | -2.44 | -5.01 | -6.46 | |
| Diluted EPS — Continuing Operations | — | -2.44 | -5.01 | -6.46 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||
| Gross Profit | — | 0.0 | -0.0 | 0.0 | |
| Gross Margin % | — | 9.43 | -24.11 | 0.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||
| Pretax Income (Adjusted, as filed) | — | 0.5 | -0.4 | -0.1 | |
| − Exceptional Items (reconciliation) | — | -0.8 | -2.6 | -2.0 | |
| Net Income Adj (tax-effected) | — | 0.5 | -0.4 | -0.7 | |
| EPS Adj | — | 3.47 | -0.67 | -1.61 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Face Value | — | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | — | 5.9 | 5.9 | 5.9 | |